![(3R,4S)-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-7,7-dimethyl-4-prop-2-enoxy-2,6,8-trioxabicyclo[3.3.0]octane structure, CAS 20316-77-2](/structures/210000/182170_2_20316_77_2.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 20316-77-2 |
| Catalog No. | 2A-4181253 |
| Chinese Name | (3R,4S)-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-7,7-dimethyl-4-prop-2-enoxy-2,6,8-trioxabicyclo[3.3. |
| Synonyms | 3-o-allyl-1,2:5,6-di-o-isopropylidene-a-d- glucofuranose |
| Molecular Formula | C15H24O6 |
| Molecular Weight | 300.34700 |
| Purity | 98% |
| PubChem ID | 16036910 |
| SMILES | C=CCOC1C(C2COC(C)(C)O2)OC2OC(C)(C)OC21 |
| InChI | InChI=1S/C15H24O6/c1-6-7-16-11-10(9-8-17-14(2,3)19-9)18-13-12(11)20-15(4,5)21-13/h6,9-13H,1,7-8H2,2-5H3/t9-,10-,11+,12?,13?/m1/s1 |
| InChI Key | XVJPYQDFXZAPEI-VFPQWFPESA-N |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| 4(3H)-Quinazolinone, 6-(acetyloxy)- | 179688-15-4 | 2A-2181159 |
| N-BOC-2-aMino-5-hydroxypyridine | 1187930-13-7 | 2A-2181163 |
| 4-methoxy-3-(4-methylphenyl)sulfonyloxy-9-phenyl-5,8,10-trioxabicyclo[4.4.0]decan-2-ol | 6698-32-4 | 2A-4181181 |
| 1,3,5-Tri-O-benzoyl-2-O-(trifluoromethanesulfonyl)-a-D-ribofuranose | 97614-41-0 | 2A-4181241 |
| (3R,4S)-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-4-methoxy-7,7-dimethyl-2,6,8-trioxabicyclo[3.3.0]octane | 43138-64-3 | 2A-4181252 |
| 2-[[(3R,4S)-3-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-7,7-dimethyl-2,6,8-trioxabicyclo[3.3.0]oct-4-yl]oxy]-N,N-dimethyl-ethanamine | 67441-19-4 | 2A-4181254 |
| 3-(2,2-dimethyl-1,3-dioxolan-4-yl)-7,7-dimethyl-2,6,8-trioxabicyclo[3.3.0]octane | 4613-62-1 | 2A-4181260 |
| (R)-2-Amino-4-cyclohexylbutanoic acid | 728880-26-0 | 2A-2181286 |
| (S)-alpha-Aminocyclohexaneacetic acid hydrochloride | 191611-20-8 | 2A-2181289 |
| (R)-HOMO-BETA-ALANINE HYDROCHLORIDE | 58610-42-7 | 2A-2181290 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA